Tripathi N, Flora S J
Division of Pharmacology and Toxicology, Defence Research and Development Establishment, Gwalior, India.
Biomed Environ Sci. 1998 Mar;11(1):38-45.
The effects of meso 2, 3-dimercaptosuccinic acid (DMSA), sodium 2, 3-dimercaptopropane 1-sulfonate (DMPS) and S-adenosyl L-methionine (SAM) on the enzymatic activities of mice were studied. The mice were given intraperitoneal (i.p.) injections of these chelating agents (1 mmol/kg) and 3 h later the activity of delta-aminolevulinic acid dehydratase (ALAD) in the blood, and aspartate aminotransferase (AST), alanine aminotransferase (ALT), gamma-glutamyltranspeptidase (gamma-GT), alkaline phosphatase (ALP) in the liver and kidney were determined. The activity of blood ALAD was significantly increased by the administration of DMSA and SAM while DMPS had only a moderate effect. The activities of other hepatic enzymes changed little when the mice were treated with these chelating agents, except for a significant reduction in hepatic ALP activity following DMPS administration. Arsenic (III) administration markedly increased the activities of ALT and ALP in the liver and kidneys. The changes in the enzymatic activities by treatment with arsenic were prevented by injection of DMSA, DMPS and SAM, DMSA being the most effective. These results indicate that DMSA, DMPS and SAM were not toxic to the liver or kidneys of mice and that treatment with DMSA is more effective than DMPS or SAM in protecting mice from acute hepatic or renal toxicity caused by arsenic.
研究了内消旋2,3-二巯基丁二酸(DMSA)、2,3-二巯基丙烷-1-磺酸钠(DMPS)和S-腺苷-L-蛋氨酸(SAM)对小鼠酶活性的影响。给小鼠腹腔注射这些螯合剂(1 mmol/kg),3小时后测定血液中δ-氨基乙酰丙酸脱水酶(ALAD)的活性,以及肝脏和肾脏中天冬氨酸转氨酶(AST)、丙氨酸转氨酶(ALT)、γ-谷氨酰转肽酶(γ-GT)、碱性磷酸酶(ALP)的活性。给予DMSA和SAM后,血液中ALAD的活性显著增加,而DMPS只有中等程度的影响。当用这些螯合剂处理小鼠时,其他肝脏酶的活性变化不大,但给予DMPS后肝脏ALP活性显著降低除外。给予砷(III)可显著增加肝脏和肾脏中ALT和ALP的活性。注射DMSA、DMPS和SAM可防止砷处理引起的酶活性变化,其中DMSA最为有效。这些结果表明,DMSA、DMPS和SAM对小鼠肝脏或肾脏无毒,并且在保护小鼠免受砷引起的急性肝毒性或肾毒性方面,DMSA的治疗效果比DMPS或SAM更有效。